MBD2 and pulmonary fibrosis: Multiple studies by Congyi Wang have shown that MBD2 levels are elevated in both IPF patients and bleomycin-induced pulmonary fibrosis model mice, particularly in the myofibroblasts within fibrotic lungs [49].